Provided by Tiger Trade Technology Pte. Ltd.

Rhythm Pharmaceuticals Inc.

110.00
+1.080.99%
Post-market: 110.000.00000.00%19:30 EDT
Volume:523.14K
Turnover:57.65M
Market Cap:7.57B
PE:-35.29
High:112.59
Open:109.38
Low:106.58
Close:108.92
52wk High:122.20
52wk Low:74.50
Shares:68.85M
Float Shares:65.39M
Volume Ratio:1.08
T/O Rate:0.80%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-3.1172
EPS(LYR):-3.1100
ROE:-117.04%
ROA:-30.96%
PB:73.54
PE(LYR):-35.37

Loading ...

Rhythm Pharmaceuticals Is Maintained at Market Outperform by Citizens

Dow Jones
·
Mar 20

BUZZ-U.S. STOCKS ON THE MOVE-Unilever, Gemini Space Station, FedEx

Reuters
·
Mar 20

S&P 500 Futures Decline In Premarket Trading; Super Micro Computer, Royalty Pharma Lag

Dow Jones
·
Mar 20

Wells Fargo Sticks to Its Buy Rating for Rhythm Pharmaceuticals (RYTM)

TIPRANKS
·
Mar 20

Rhythm Pharmaceuticals Inc : Leerink Partners Raises Target Price to $142 From $136

THOMSON REUTERS
·
Mar 20

Rhythm Pharma Shares Gain 7.4% Premarket After FDA Clears Its Treatment for Brain Damage-Related Obesity

THOMSON REUTERS
·
Mar 20

BUZZ-Rhythm Pharma rises after FDA clears therapy for hypothalamic obesity

Reuters
·
Mar 20

Rhythm Pharmaceuticals trading halted, news pending

TIPRANKS
·
Mar 20

FDA approves Rhythm Pharmaceuticals' IMCIVREE for acquired hypothalamic obesity in patients aged 4 and older

Reuters
·
Mar 20

Rhythm Pharmaceuticals Announces FDA Approval of Imcivree® (Setmelanotide) for Patients With Acquired Hypothalamic Obesity

THOMSON REUTERS
·
Mar 20

NASDAQ TRADE HALT HALT NEWS PENDING AT 06:25 PM

Reuters
·
Mar 20

Rhythm price target lowered to $100 from $110 at H.C. Wainwright

TIPRANKS
·
Mar 18

Rhythm Pharmaceuticals, Inc. : H.c. Wainwright Cuts Target Price to $100 From $110

THOMSON REUTERS
·
Mar 18

These Stocks Are Today's Movers: Nvidia, Oklo, Delta, Carnival, Uber, Honeywell, Elbit, and More -- Barrons.com

Dow Jones
·
Mar 17

Rhythm Pharmaceuticals Inc : Leerink Partners Cuts Target Price to $136 From $142

THOMSON REUTERS
·
Mar 17

Rhythm Pharmaceuticals Is Maintained at Buy by Needham

Dow Jones
·
Mar 17

Guggenheim Sticks to Its Buy Rating for Rhythm Pharmaceuticals (RYTM)

TIPRANKS
·
Mar 17

Analysts Offer Insights on Healthcare Companies: Rhythm Pharmaceuticals (RYTM) and Merck & Company (MRK)

TIPRANKS
·
Mar 17

RBC Lowers Price Target on Rhythm Pharmaceuticals to $130 From $140, Keeps Outperform, Speculative Risk

MT Newswires Live
·
Mar 17

Rhythm Pharmaceuticals Inc : Needham Cuts Target Price to $130 From $139

THOMSON REUTERS
·
Mar 17